Psychedelic Drugs: Regulators Still Unsure On Development Path, But Willing To Listen

 
• By Derrick Gingery
  
mushrooms
An EMA official said sponsors may have to think out of box in designing psychedelic clinical trials. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D